ZA807634B - New 2-methyl-6-substituted-4-(2,3-dichlorophenyl-1,4-dihydropyridine)-3,5-dicarboxylic acid-3,5-diesters having hypotensive properties,as well as process for their preparation and pharmaceutical preparations containing same - Google Patents

New 2-methyl-6-substituted-4-(2,3-dichlorophenyl-1,4-dihydropyridine)-3,5-dicarboxylic acid-3,5-diesters having hypotensive properties,as well as process for their preparation and pharmaceutical preparations containing same

Info

Publication number
ZA807634B
ZA807634B ZA00807634A ZA807634A ZA807634B ZA 807634 B ZA807634 B ZA 807634B ZA 00807634 A ZA00807634 A ZA 00807634A ZA 807634 A ZA807634 A ZA 807634A ZA 807634 B ZA807634 B ZA 807634B
Authority
ZA
South Africa
Prior art keywords
dihydropyridine
diesters
dichlorophenyl
substituted
methyl
Prior art date
Application number
ZA00807634A
Other languages
English (en)
Inventor
S Carlsson
P Berntsson
J Gaarder
B Ljung
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Publication of ZA807634B publication Critical patent/ZA807634B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
ZA00807634A 1979-12-20 1980-12-05 New 2-methyl-6-substituted-4-(2,3-dichlorophenyl-1,4-dihydropyridine)-3,5-dicarboxylic acid-3,5-diesters having hypotensive properties,as well as process for their preparation and pharmaceutical preparations containing same ZA807634B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7910521A SE7910521L (sv) 1979-12-20 1979-12-20 Nya 2-metyl-6-substituerade-4-(2,3-disubstituerad fenyl)-1,4-dihydropyridin-3,5-diestrar med hypotesiva egenskaper, samt forfarande for deras framstellning, och farmaceutiska beredningar innehallande desamma

Publications (1)

Publication Number Publication Date
ZA807634B true ZA807634B (en) 1981-11-25

Family

ID=20339605

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA00807634A ZA807634B (en) 1979-12-20 1980-12-05 New 2-methyl-6-substituted-4-(2,3-dichlorophenyl-1,4-dihydropyridine)-3,5-dicarboxylic acid-3,5-diesters having hypotensive properties,as well as process for their preparation and pharmaceutical preparations containing same

Country Status (11)

Country Link
EP (1) EP0031801A3 (xx)
JP (1) JPS56127356A (xx)
AU (1) AU6542380A (xx)
DD (1) DD155519A5 (xx)
DK (1) DK539980A (xx)
ES (4) ES8204720A1 (xx)
FI (1) FI803984L (xx)
MY (1) MY8500404A (xx)
NO (1) NO803856L (xx)
SE (1) SE7910521L (xx)
ZA (1) ZA807634B (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3018259A1 (de) * 1980-05-13 1981-11-19 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridine mit unterschiedlichen substituenten in 2- und 6-position, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DK161312C (da) * 1982-03-11 1991-12-09 Pfizer Analogifremgangsmaade til fremstilling af 2-aminoalkoxymethyl-4-phenyl-6-methyl-1,4-dihydropyridin-3,5-dicarboxylsyreestere eller syreadditionssalte deraf samt phthalimidoderivater til anvendelse som udgangsmateriale ved fremgangsmaaden
IL68604A0 (en) * 1982-05-21 1983-09-30 Haessle Ab Processes for preparing therapeutically active dihydropyridines and intermediates for the processes
DE3363743D1 (en) * 1982-07-22 1986-07-03 Pfizer Ltd Dihydropyridine anti-ischaemic and antihypertensive agents
HU192166B (en) * 1982-08-06 1987-05-28 Banyu Pharma Co Ltd Process for producing 2-carbamoyl-oxy-alkyl-1,4-dihydro-pyridine derivatives
PH19166A (en) * 1982-09-04 1986-01-16 Pfizer Dihydropyridined,pharmaceutical compositions and method of use
EP0107293A3 (en) * 1982-09-04 1984-06-06 Pfizer Limited Dihydropyridines
US4572908A (en) * 1982-12-21 1986-02-25 Pfizer Inc. Dihydropyridines
US4515799A (en) * 1983-02-02 1985-05-07 Pfizer Inc. Dihydropyridine anti-ischaemic and antihypertensive agents
GB8306666D0 (en) * 1983-03-10 1983-04-13 Pfizer Ltd Therapeutic agents
GB8412208D0 (en) * 1984-05-12 1984-06-20 Pfizer Ltd Quinolone inotropic agents
GB8415386D0 (en) * 1984-06-15 1984-07-18 Pfizer Ltd Therapeutic agents
GB8526411D0 (en) * 1985-10-25 1985-11-27 Pfizer Ltd Dihydropyridines
GB8527698D0 (en) * 1985-11-09 1985-12-11 Pfizer Ltd Dihydropyridine antiischaemic & antihypertensive agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2117572C3 (de) * 1971-04-10 1980-03-20 Bayer Ag, 5090 Leverkusen Unsymmetrische 1,4-Dihydropyridin ^-dicarbonsäureester, Verfahren zu ihrer Herstellung sowie ihre Verwendung als Arzneimittel
SE429652B (sv) * 1978-06-30 1983-09-19 Haessle Ab 2.6-dimetyl-4-(2.3-diklorfenyl)-1.4-dihydropyridin-3.5-dikarboxylsyra-3-metylester-5-etylester
CA1117117A (en) * 1978-10-10 1982-01-26 Fujisawa Pharmaceutical Co., Ltd. 2-methyl-dihydropyridine compound, processes for preparation thereof and pharmaceutical composition comprising the same

Also Published As

Publication number Publication date
SE7910521L (sv) 1981-06-21
ES497927A0 (es) 1982-05-01
ES508031A0 (es) 1982-10-01
MY8500404A (en) 1985-12-31
DK539980A (da) 1981-06-21
ES8307220A1 (es) 1982-11-16
JPS56127356A (en) 1981-10-06
DD155519A5 (de) 1982-06-16
FI803984L (fi) 1981-06-21
NO803856L (no) 1981-06-22
ES8306109A1 (es) 1982-10-01
EP0031801A3 (en) 1981-09-16
AU6542380A (en) 1981-06-25
ES508024A0 (es) 1982-11-16
ES8204720A1 (es) 1982-05-01
ES8307221A1 (es) 1982-11-01
EP0031801A2 (en) 1981-07-08
ES508025A0 (es) 1982-11-01

Similar Documents

Publication Publication Date Title
IL53639A0 (en) New 1,4-dihydropyridine derivatives their preparation and pharmaceutical compositions containing them
PT83143A (en) Process for preparing 2-thiomethyl-substituted-1,4-dihydropyridines and pharmaceutical compositions containing them
DE3273783D1 (en) Novel piperidine derivatives, processes for preparation thereof and pharmaceutical compositions containing same
GB2037766B (en) 1,4-dihydropyridines their preparation and pharmaceutical compositions containing them
ZA777532B (en) 1,4-dihydropyridine compounds,process for preparation thereof and pharmaceutical composition of the same
ZA807634B (en) New 2-methyl-6-substituted-4-(2,3-dichlorophenyl-1,4-dihydropyridine)-3,5-dicarboxylic acid-3,5-diesters having hypotensive properties,as well as process for their preparation and pharmaceutical preparations containing same
DE2963573D1 (en) Isoquinoline derivatives, process for their preparation and pharmaceutical compositions containing them
DE3066434D1 (en) Novel piperidine derivatives, method for the preparation thereof and pharmaceutical compositions containing them
IL75943A (en) 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
GR3001416T3 (en) Substituted amino-dihydrooxazoles, -thiazoles and -imidazoles, process for their preparation and pharmaceutical compositions containing them
EP0172004A3 (en) Quinolinones, process for their preparation and pharmaceutical compositions containing them
IL70845A0 (en) 1,2,3,4,4a,5,10,10a-octahydrobenzo(g)quinoline derivatives,their production and pharmaceutical compositions containing them
IL56808A0 (en) 1-oxo-1h-pyrimido(6,1)benztheazole derivatives,process forthe preparation thereof and pharmaceutical compositions containing the same
IL72152A0 (en) 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
ZA792042B (en) Substituted 8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1h-3-benzazepines,process for the preparation thereof and pharmaceutical compositions containing them
IL84955A0 (en) Novel carbamoyloxylabdanes,process for the preparation thereof and pharmaceutical compositions containing them
IL84791A0 (en) Substituted aminopropionamides,process for their preparation and pharmaceutical compositions containing them
ZA843084B (en) Pyridines,process for their preparation and pharmaceutical compositions thereof
PT84339A (pt) 1,6-naphthyridine derivatives process for the preparation thereof and pharmaceutical compositions containing them
IL57720A0 (en) Phenylpiperidine derivatives,their preparation and pharmaceutical compositions containing them
IL76327A0 (en) Phenylacetonitrile derivatives,process for the preparation thereof and pharmaceutical compositions containing the same
ZA843712B (en) 2,6-disubstituted-1,4-dihydropyridine derivative,process for the preparation of the same and pharmaceutical composition comprising the same
DE2967215D1 (en) Isoquinoline derivatives, process for their preparation, intermediates and pharmaceutical compositions containing them
IL57129A (en) 6,7-benzomorphan derivatives,their production and pharmaceutical compositions containing them
GB2190678B (en) 3-(hydroxymethyl)-isoquinoline derivatives, process for the preparation thereof and pharmaceutical compositions containing the same